
Ciloa SAS secures €6.5m to advance lead candidate APN-sEV into clinical development
Montpellier-based Ciloa SAS, a spin-out founded in 2011 by CEO Robert Mamoun (INSERM) and CSO Bernadette Trentin (University of Montpellier), has secured €6.5m under Bpifrance’s “Innovation in Biotherapies and Biomanufacturing” initiative, part of the …